Thor Medical ASA (OSL:TRMED)
Norway · Delayed Price · Currency is NOK 4.790
+0.090 (1.91%)
Sep 14, 2026, 12:42 PM CET
Thor Medical ASA Market Cap
Thor Medical ASA has a market cap or net worth of 1.99 billion as of September 11, 2026. Its market cap has increased by 38.56% in one year.
Market Cap
1.99B
Enterprise Value
2.17B
Revenue
1.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.79
ChartMarket Cap Chart
Since July 4, 2023, Thor Medical ASA's market cap has increased from 466.61M to 1.99B, an increase of 325.57%. That is a compound annual growth rate of 57.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 14, 2026 | 1.99B | 6.82% |
| Dec 30, 2025 | 1.86B | 151.99% |
| Dec 30, 2024 | 737.69M | 144.87% |
| Dec 29, 2023 | 301.27M | -35.44% |
| Jul 4, 2023 | 466.61M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Circio Holding ASA | 3.50B |
| Nykode Therapeutics AS | 1.29B |
| ArcticZymes Technologies ASA | 1.08B |
| Lytix Biopharma ASA | 645.96M |
| Zelluna ASA | 602.98M |
| Oncoinvent ASA | 602.35M |
| SoftOx Solutions AS | 312.22M |
| Aqua Bio Technology ASA | 75.14M |